A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status:
Recruiting
Trial end date:
2023-04-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and tolerability of JNJ-67484703
administrations in participants with active rheumatoid arthritis (RA) despite receiving
methotrexate (MTX) therapy.